Proliferation Inhibition and Cell Cycle Arrest of Human Hepatoma HepG-2 Cell Induced by Cinobufacini Injection
Xiaonan Cui
Abstract
Xiaonan Cui
Abstract
Objective To study the effect of cinobufacin injection on the proliferation and cell cycle of human hepatoma HepG-2 cell. Methods Cell proliferation was analysed by MTT assay; Flow cytometry (FCM) was emplayed to detect tumor cell cycle distribution; Expression of CyclinA, CDK2 mRNA levels in HepG-2 cells was analysed by PT-PCR;Quantitative colorimetric assay was used to analyse cyclinA/CDK2 activity in HepG-2 cells .Results Cinobufacini injection significantly inhibited HepG-2 cells proliferation in doses-and time-dependent ways;FCM analysis expressed cinobufacin injection induced cell cycle arrest at S phase ;PT-PCR assay showed cinobufacin injection down-regulated CDK2, CyclinA expression at mRNA levels; Quantitative colorimetric assay displayed cinobufacin injection deceased cyclinA/CDK2 activity in HepG-2 cells.Conclusion Human hepotocarcinoma HepG-2 cell growth can be inhibited and cell cycle can be induced to arrest at S phase through injection.Conclusion The mechanism might be partly related to the down-regulation of CDK2, CyclinA expression and inhibition of cyclinA/CDK2 activity .
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the effect of cinobufacin injection on the proliferation and cell cycle of human hepatoma HepG-2 cell. Methods Cell proliferation was analysed by MTT assay; Flow cytometry (FCM) was emplayed to detect tumor cell cycle distribution; Expression of CyclinA, CDK2 mRNA levels in HepG-2 cells was analysed by PT-PCR;Quantitative colorimetric assay was used to analyse cyclinA/CDK2 activity in HepG-2 cells .Results Cinobufacini injection significantly inhibited HepG-2 cells proliferation in doses-and time-dependent ways;FCM analysis expressed cinobufacin injection induced cell cycle arrest at S phase ;PT-PCR assay showed cinobufacin injection down-regulated CDK2, CyclinA expression at mRNA levels; Quantitative colorimetric assay displayed cinobufacin injection deceased cyclinA/CDK2 activity in HepG-2 cells.Conclusion Human hepotocarcinoma HepG-2 cell growth can be inhibited and cell cycle can be induced to arrest at S phase through injection.Conclusion The mechanism might be partly related to the down-regulation of CDK2, CyclinA expression and inhibition of cyclinA/CDK2 activity .
Key concepts: Cell cycle, Flow cytometry, Cyclin-dependent kinase 2, Cell growth, Cell cycle checkpoint, MTT assay, Cell, Cell biology